FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to liposomal compositions for application in cosmetic industry, including i) from 0.001 to 1 wt % of cyclo-(Arg-Gly-Asp-DPhe-Acha) and/or its salt or solvate, ii) from 0.01 to 20 wt % of one or more lipids; iii) from 60 to 99.99 wt % of one or more physiologically acceptable solvents, as well as to method of their obtaining and application for care and preservation of general condition of skin or hare, for prevention or reduction of wrinkles.
EFFECT: claimed compositions demonstrate favourable properties: improved effectiveness, higher stability, reduced immunogenic reactions in comparison with known properties.
18 cl, 3 dwg, 29 tbl, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING CYCLO-(ARG-GLY-ASP-D-PHE-N-MEVAL) | 2000 |
|
RU2243974C2 |
| CYCLIC INHIBITORS OF ADHESION | 1997 |
|
RU2184121C2 |
| CYCLOPEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2157379C2 |
| CONJUGATES OF PHOSPHOLIPIDS AND DIRECTION VECTOR MOLECULES | 2006 |
|
RU2433137C2 |
| METHODS FOR TREATMENT OF TUMORS AND METASTASIS USING COMBINATION OF ANTI-ANGIOGENIC THERAPY AND IMMUNOTHERAPY | 2000 |
|
RU2236251C2 |
| CYCLIC AZAPEPTIDES WITH ANGIOGENIC EFFECT | 1998 |
|
RU2188205C2 |
| TECHNIQUES AND COMPOSITIONS USED TO INHIBIT αβ-CAUSED ANGIOGENESIS | 1997 |
|
RU2195312C2 |
| METHODS AND COMPOSITIONS USED FOR INHIBITING ANGIOGENESIS | 1997 |
|
RU2194528C2 |
| LIQUID PREPARATION CONTAINING OLIGOPEPTIDES AND ESTERIFIED CYCLODEXTRIN | 2003 |
|
RU2322254C2 |
| COMBINED THERAPY USING INHIBITORS OF TYROSINE KINASE RECEPTORS AND INHIBITORS OF ANGIOGENESIS | 2001 |
|
RU2292904C2 |
